TREM1 inhibition decreases HIV mediated inflammatory cytokine production. by Jinhee Hyun (6900683)

Supplementary data: Decreased efficacy of sofosbuvir/velpatasvirin HIV patients coinfected with HCVgenotype 3b by Jing Zhou (168494)

Image_1_The Negative Impact of COVID-19 in HCV, HIV, and HPV Surveillance Programs During the Different Pandemic Waves.tif by Beatriz Romero-Hernández (3146868)

Subjects:

HCV infection decreases L1 retrotransposition frequency. by Anja Schöbel (10668438)

The protein level of ApoB was decreased in HCV-infected cells. by Bei Wang (116772)

Subjects:

Table1_Baseline Plasma Metabotype Correlates With Direct-Acting Antiviral Therapy Nonresponse for HCV in HIV–HCV Coinfected Patients.XLSX by Gaurav Tripathi (3163251)

“…<p>Introduction: With the advent of direct-acting antiviral (DAA) therapy for HCV, the cure is achieved at similar rates among HIV–HCV coinfected patients as in HCV mono-infected patients. …”

Expression of ApoB-50 decreased lipid accumulation and inhibited HCV production. by Bei Wang (116772)

Subjects:

Image_1_Mitochondrial topoisomerase 1 inhibition induces topological DNA damage and T cell dysfunction in patients with chronic viral infection.jpeg by Xindi Dang (10742208)

“…We found that Top1mt protein levels and enzymatic activity are significantly decreased, along with Top1 cleavage complex (Top1cc) formation, in mitochondria of CD4 T cells from HCV- and HIV-infected patients. …”

Image_2_Mitochondrial topoisomerase 1 inhibition induces topological DNA damage and T cell dysfunction in patients with chronic viral infection.tif by Xindi Dang (10742208)

“…We found that Top1mt protein levels and enzymatic activity are significantly decreased, along with Top1 cleavage complex (Top1cc) formation, in mitochondria of CD4 T cells from HCV- and HIV-infected patients. …”

Table_1_HIV and HCV screening by non-infectious diseases physicians: can we improve testing and hidden infection rates?.docx by Alejandro G. García-Ruiz de Morales (16445565)

“…Before the session, 19.9% (28% medical, 8% surgical) and 17.9% (30% medical, 2.7% surgical) were aware of HIV and HCV testing guidelines, respectively. The willingness to routinely test increased from 5.6 to 22%, whereas not ordering tests decreased from 34.1 to 2.4%. …”

pGab1 levels decreased over time in HCV-infected Huh7.5.1 cells. by Da-eun Nam (18927946)

Loss of virulence in the SIN kinase mutants is characterized by decreased fungal burden and host response to infection. by Ana Camila Oliveira Souza (8180958)

“…Quantitation of IL-1β <b>(B)</b> and TNFα <b>(C)</b> revealed decreased host response in SIN kinase mutant infected mice. …”

ApoB was degraded by the proteasome in HCV-infected cells. by Bei Wang (116772)

Subjects:

Cyclooxygenase inhibition decreases immune control of fungal germination and invasive hyphal growth. by Savini Thrikawala (5690510)

Decreased virulence observed during <i>in planta</i> infection with <i>ΔFgknr4</i>. by Erika Kroll (20537020)

“…Ab = abaxial wheat cell layer, ad = adaxial wheat cell layer, as = air spaces, and h = fungal hyphae. In wheat inoculated with <i>ΔFgknr4</i> compared to WT, decreased host colonisation is observed, evidenced by (i) reduced fungal hyphae proliferation, particularly in the thicker adaxial cell layer, (ii) collapsed air spaces in wheat cells, and (iii) increased polymer deposition at the wheat cell walls (black arrows), indicating an enhanced defence response. …”

Treatment with low doses of GI254023X causes a mild decrease in ADAM10 surface expression that correlates with a marked impairment of HCV infectivity. by Belén Carriquí-Madroñal (17396512)

Impacts of other apolipoproteins on HCV assembly. by Bei Wang (116772)

Subjects:

Absolute CD4 T cell proliferation and plasma IL-7 levels are decreased in treated HIV infection. by Charline Bacchus-Souffan (10005048)

PGRN deletion decreased the susceptibility to invasive <i>C</i>.<i>albicans</i> infection in mice. by Jiayu Liu (3951515)

Expression of antioxidants on day 9 of post infection. by Sobia Manzoor (11372369)

Subjects: